Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Generation and selection of antibodies for a novel immunochromatographic lateral flow test to rapidly identify OXA-23-like-mediated carbapenem resistance in Acinetobacter baumannii.

Mertins S, Higgins PG, Rodríguez MG, Borlon C, Gilleman Q, Mertens P, Seifert H, Krönke M, Klimka A.

J Med Microbiol. 2019 Jul;68(7):1021-1032. doi: 10.1099/jmm.0.001015. Epub 2019 Jun 12.

PMID:
31188094
2.

Does Waterborne Exposure Explain Effects Caused by Neonicotinoid-Contaminated Plant Material in Aquatic Systems?

Englert D, Zubrod JP, Link M, Mertins S, Schulz R, Bundschuh M.

Environ Sci Technol. 2017 May 16;51(10):5793-5802. doi: 10.1021/acs.est.7b00827. Epub 2017 May 3.

PMID:
28447782
3.

Oral antigen exposure in newborn piglets circumvents induction of oral tolerance in response to intraperitoneal vaccination in later life.

Pasternak JA, Ng SH, Buchanan RM, Mertins S, Mutwiri GK, Gerdts V, Wilson HL.

BMC Vet Res. 2015 Mar 7;11:50. doi: 10.1186/s12917-015-0350-8.

4.

Cancer stem cells: a systems biology view of their role in prognosis and therapy.

Mertins SD.

Anticancer Drugs. 2014 Apr;25(4):353-67. doi: 10.1097/CAD.0000000000000075. Review.

5.
6.

Role of motAB in adherence and internalization in polarized Caco-2 cells and in cecal colonization of Campylobacter jejuni.

Mertins S, Allan BJ, Townsend HG, Köster W, Potter AA.

Avian Dis. 2013 Mar;57(1):116-22.

PMID:
23678739
7.

A small molecule (pluripotin) as a tool for studying cancer stem cell biology: proof of concept.

Mertins SD, Scudiero DA, Hollingshead MG, Divelbiss RD Jr, Alley MC, Monks A, Covell DG, Hite KM, Salomon DS, Niederhuber JE.

PLoS One. 2013;8(2):e57099. doi: 10.1371/journal.pone.0057099. Epub 2013 Feb 21.

8.

Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel.

Stuelten CH, Mertins SD, Busch JI, Gowens M, Scudiero DA, Burkett MW, Hite KM, Alley M, Hollingshead M, Shoemaker RH, Niederhuber JE.

Stem Cells. 2010 Apr;28(4):649-60. doi: 10.1002/stem.324.

9.

Modulation of PrfA activity in Listeria monocytogenes upon growth in different culture media.

Stoll R, Mertins S, Joseph B, Müller-Altrock S, Goebel W.

Microbiology. 2008 Dec;154(Pt 12):3856-76. doi: 10.1099/mic.0.2008/018283-0.

PMID:
19047753
10.

Carbon metabolism of Listeria monocytogenes growing inside macrophages.

Eylert E, Schär J, Mertins S, Stoll R, Bacher A, Goebel W, Eisenreich W.

Mol Microbiol. 2008 Aug;69(4):1008-17. doi: 10.1111/j.1365-2958.2008.06337.x. Epub 2008 Jul 9.

11.

Glycerol metabolism and PrfA activity in Listeria monocytogenes.

Joseph B, Mertins S, Stoll R, Schär J, Umesha KR, Luo Q, Müller-Altrock S, Goebel W.

J Bacteriol. 2008 Aug;190(15):5412-30. doi: 10.1128/JB.00259-08. Epub 2008 May 23.

12.

The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.

Stein U, Arlt F, Walther W, Smith J, Waldman T, Harris ED, Mertins SD, Heizmann CW, Allard D, Birchmeier W, Schlag PM, Shoemaker RH.

Gastroenterology. 2006 Nov;131(5):1486-500. Epub 2006 Aug 22.

PMID:
17101323
13.

Interference of components of the phosphoenolpyruvate phosphotransferase system with the central virulence gene regulator PrfA of Listeria monocytogenes.

Mertins S, Joseph B, Goetz M, Ecke R, Seidel G, Sprehe M, Hillen W, Goebel W, Müller-Altrock S.

J Bacteriol. 2007 Jan;189(2):473-90. Epub 2006 Nov 3.

14.

Species-specific differences in the activity of PrfA, the key regulator of listerial virulence genes.

Mauder N, Ecke R, Mertins S, Loeffler DI, Seidel G, Sprehe M, Hillen W, Goebel W, Müller-Altrock S.

J Bacteriol. 2006 Nov;188(22):7941-56. Epub 2006 Sep 15.

15.

Overexpression of PrfA leads to growth inhibition of Listeria monocytogenes in glucose-containing culture media by interfering with glucose uptake.

Marr AK, Joseph B, Mertins S, Ecke R, Müller-Altrock S, Goebel W.

J Bacteriol. 2006 Jun;188(11):3887-901.

16.

In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity.

Mertins SD, Myers TG, Holbeck SL, Medina-Perez W, Wang E, Kohlhagen G, Pommier Y, Bates SE.

Mol Cancer Ther. 2004 Jul;3(7):849-60.

17.

Screening for and identification of novel agents directed at renal cell carcinoma.

Mertins SD, Myers TG, Hollingshead M, Dykes D, Bodde E, Tsai P, Jefferis CA, Gupta R, Linehan WM, Alley M, Bates SE.

Clin Cancer Res. 2001 Mar;7(3):620-33.

18.

P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228.

Sandor V, Senderowicz A, Mertins S, Sackett D, Sausville E, Blagosklonny MV, Bates SE.

Br J Cancer. 2000 Sep;83(6):817-25.

19.

Intrinsic drug resistance in primary and metastatic renal cell carcinoma.

Gamelin E, Mertins SD, Regis JT, Mickley L, Abati A, Worrell RA, Linehan WM, Bates SE.

J Urol. 1999 Jul;162(1):217-24.

PMID:
10379790
20.

Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens.

Roilides E, Lyman CA, Mertins SD, Cole DJ, Venzon D, Pizzo PA, Chanock SJ, Walsh TJ.

Cytokine. 1996 Jan;8(1):42-8.

PMID:
8742065
22.

IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis.

Jablons D, Bolton E, Mertins S, Rubin M, Pizzo P, Rosenberg SA, Lotze MT.

J Immunol. 1990 May 1;144(9):3630-6.

PMID:
2158514
23.

Role of polymorphonuclear leukocytes in infection by retroviruses with emphasis on the human immunodeficiency virus.

Mertins SD, Ortona L, Cauda R.

Viral Immunol. 1990 Fall;3(3):173-94. Review.

PMID:
2175193

Supplemental Content

Loading ...
Support Center